• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On September 9th, it was reported that from September 5th to 8th, the National Healthcare Security Administration organized on-site price negotiations for the 2026 National Basic Medical Insurance Drug Catalog. Over a hundred domestic and foreign companies participated, and 124 drugs not currently on the catalog were shortlisted for the negotiation stage. Innovative drugs in key areas of public concern, such as oncology, rare diseases, chronic diseases, and pediatric medications, participated in the negotiations and are expected to be included in the medical insurance catalog. Simultaneously, the adjustment of the commercial health insurance innovative drug catalog was also carried out, with 12 drugs shortlisted for on-site price negotiations. The 2026 National Medical Insurance Drug Catalog and the commercial health insurance innovative drug catalog are expected to be released in November this year and officially implemented on January 1, 2027.The mayor of Novorossiysk, Russia, said that the attack on the city by Ukraine resulted in four deaths.The Ministry of Justice of Kazakhstan: Enforcement actions against the North Caspian Oil Corporation are ongoing.Gatwick Airport, UK: Flights at London Gatwick Airport have now resumed. We still expect it will take some time for operations to fully return to normal.1. New CEOs Debut – Ternus, who has served as Apples head of hardware since 2021, has hosted numerous Apple product launches, but this will be his first appearance as CEO. This event will be his first opportunity to showcase his vision for the company. 2. The Long-Standing Issue of iPhone Price Increases – Pricing of the new products is perhaps one of the most anticipated issues at this event. Apple has taken measures this year to mitigate the impact of rising chip prices, and it is reported that it will raise the prices of the iPhone 18 Pro and iPhone 18 Pro Max by $100 each, a smaller increase than previously expected. 3. First Foldable iPhone – Apple is reportedly naming its first foldable phone the "iPhone Duo," with a starting price of $2,000. The entry-level version will come with 256GB of storage, and Apple will also release a larger capacity version, with the highest price potentially reaching around $3,000. This phone is expected to launch as early as October, offering white and dark blue color options. 4. iPhone 18 Pro Series – The iPhone 18 Pro series will look almost identical to the 17 Pro series, with one major change being the replacement of the orange color with a burgundy. However, in terms of cameras, the 18 Pro series will feature a new lens and professional-grade imaging software. A mechanical aperture may be added to the larger models, enabling more precise depth-of-field control and improving low-light performance. Furthermore, the "Isle of Light" design will be further reduced, and the series will feature the A20 Pro chip and a redesigned vapor chamber for better heat management. 5. Apple Watch and AirPods 5 – For the new Apple Watch Series 12 and Ultra 4, Apple will introduce new colors and redesign the case and band. The Series 12 will return to a ceramic case version; the Ultra 4 will have longer battery life. Additionally, Apple will introduce the entry-level AirPods 5, featuring significantly upgraded active noise cancellation. 6. Other potential new products: A home hub for controlling smart home devices, a new Apple TV with a faster processor, and a HomePod mini. Additionally, Apple is expected to announce the official release dates for iOS 27, iPadOS 27, macOS Golden Gate, tvOS 27, watchOS 27, and visionOS 27. 7. Products not expected to be released: According to media reports, the standard iPhone 18 will be delayed until next spring; in-ear AirPods will be delayed until next year; a MacBook Pro with an M6 chip and a new iMac may be released before the end of this year; a new MacBook Pro with an OLED touchscreen may be released at the end of this year or early next year; and an OLED iPad mini is expected to be released before the end of October.

BTC Fear & Greed Index Falls Despite BTC Avoiding Sub-$16,000

Jimmy Khan

Nov 24, 2022 15:40

微信截图_20221124094121.png


Bitcoin (BTC) increased by 2.44% on Wednesday. BTC finished the day at $16,613 after rising by 2.87% on Tuesday. For the first time in three sessions, BTC avoided trading below $16,000.


BTC dropped to a low of $16,168 early in the morning following a mixed day's start. BTC surged to a late high of $16,682, avoiding the First Major Support Level (S1) at $15,791. At $16,469, the First Major Resistance Level (R1) was breached by BTC, which ultimately closed the day at $16,613.


On Wednesday, FTX contagion risk decreased even further, supporting the cryptocurrency market desperately needed. Former FTX CEO Sam Bankman-Fried boosted investor hopes after learning that the company had cash reserves of $1.24 billion.


Bankman-Fried wrote in a letter to the staff, "Perhaps there still remains a chance to preserve the company. I think there are many billions of dollars in sincere interest from new investors that could be used to compensate customers. But since I have no control over it, I can't guarantee you anything.


The letter came after news that Justin Sun of Tron and Brad Garlinghouse of Ripple were interested in buying FTX assets. Investors are hopeful that the collapse of FTX will have a minimal effect on creditors given the stated cash holding of $1.24 billion.


The FOMC meeting minutes provided more assistance for the cryptocurrency market overnight. Before the holidays, talk of letting up on the gas helped riskier assets, with the NASDAQ Composite Index increasing by 0.99%. The US economic data underwhelmed, though, restricting the NASDAQ's potential growth.


Since the US markets are closed for Thanksgiving, there are no US statistics to take into account today.